NCT05914662
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT05914662
NCT06047197
NCT02131753
NCT05255354
NCT06566807
NCT05501899
NCT06479356
NCT06541327
NCT06187441
NCT06455163